Compounded semaglutide: what it is and how it's prescribed

What compounded semaglutide is

Semaglutide is a GLP-1 receptor agonist that lowers appetite and slows digestion. A compounded version is prepared by a licensed pharmacy under a prescription for one patient.

Brand products exist, such as Ozempic, Wegovy and Rybelsus. We name them only to explain the difference. Compounded semaglutide is not a generic and is not the same as a brand product. It is not FDA-approved as a finished product, and it is prescription-only.

Compounded vs brand semaglutide

Brand semaglutide is FDA-approved and made under the manufacturer's approval. Compounded semaglutide is not reviewed by the FDA for safety, effectiveness or quality before it reaches you.

FDA's page on compounded GLP-1 drugs says compounded drugs are not FDA approved and are not reviewed by the agency for safety, effectiveness or quality before they are marketed. Formulation and dosing can differ between the two. If access to a brand product matters to you, say so, and expect the clinician to discuss brand alternatives with you. For other routes to the same medicine, read the Ozempic alternatives guide.

FDA status and safety warnings

The FDA has warned about dosing errors and unverified sources of compounded semaglutide.

FDA's page on concerns with unapproved GLP-1 drugs used for weight loss, checked on 2026-10-16 (page content current as of 10/01/2026), says compounded drugs are not FDA-approved and that FDA does not review them for safety, effectiveness or quality before they are marketed. It also says compounding may be appropriate only when a patient's medical need cannot be met by an approved drug, or the approved drug is not commercially available. FDA's page may change, so read the current version before you decide. FDA reports adverse events, some needing hospitalization, that may be related to dosing errors with compounded injectable products. Patients sometimes measured and injected the wrong amount, and clinicians sometimes miscalculated doses. FDA also says adverse events from compounded versions are likely underreported. Avoid sellers that describe a product as a lab chemical or "not for human use". Measured doses and clear written instructions matter. Rush Pharmacy, a licensed U.S. compounding pharmacy, prepares Mendoxa prescriptions.

Is compounded semaglutide still allowed?

FDA's page says compounded drugs are not FDA approved, and that compounding might be appropriate when a patient's medical need cannot be met by an FDA-approved drug. It does not say that any one compounded product is approved.

The same page says compounding may also apply where the approved drug is not commercially available. It does not address shortage status, so this guide does not either. The page was opened on 2026-10-16 and lists its content as current as of 10/01/2026. Read the current FDA page before you decide, and ask the prescriber why compounded semaglutide fits your situation.

Who decides your compounded dose

The prescribing clinician and the pharmacy set a compounded dose and should give you written instructions for it. It is not the brand schedule.

FDA reports adverse events, some requiring hospitalization, that may be related to dosing errors, from patients measuring and injecting the wrong amount and from clinicians miscalculating doses. FDA advises patients to talk with their health care provider or compounder about how to measure and administer the intended dose. For the brand schedule, read the Wegovy starting dose guide.

Questions to ask before you start

Ask who the prescriber is, which pharmacy fills the prescription, how the dose is written on the label, and who to call about side effects.

FDA says patients should obtain a prescription from their doctor and fill it at a state-licensed pharmacy. It lists red flags for online sellers, including deep discounts and no required doctor screening. Ask the clinician to explain the dose in the units on the label and how to measure it before the first injection.

Side effects and who should not take it

The most common side effects are nausea, vomiting, diarrhea and constipation, especially as the dose goes up. Some people should not take semaglutide at all.

Serious risks include pancreatitis, gallbladder problems, low blood sugar when combined with some diabetes drugs, and kidney problems from dehydration. Brand semaglutide products carry a boxed warning about thyroid C-cell tumors, so they are not for people with a personal or family history of medullary thyroid cancer or MEN 2. Pregnancy is not appropriate. Tell the clinician about every medication. See the semaglutide prescribing information on DailyMed.

Injection vs brand tablet

Semaglutide comes as a weekly injection and as a brand tablet. The brand tablet is a different product from a compounded injection, and the public Mendoxa offer is the injection.

The brand tablet is an FDA-approved product with its own label and its own instructions, so follow that label if you are prescribed it. Brand injections are given weekly with the dose raised in steps. Compounded versions have not been reviewed by the FDA. The clinician decides whether an injection is appropriate and sets the dose.

Semaglutide online: how to check a provider

A real provider has a licensed clinician review your history and names the pharmacy that fills it. Avoid anyone who skips either.

The intake should ask about your weight history, health conditions and medications. Red flags include no clinician review, no named pharmacy, and products sold as lab chemicals. A prescription is never automatic. Mendoxa serves 49 states (not California), LocumTele clinicians review every intake, and Rush Pharmacy fills when a prescription is issued.